Rchr
J-GLOBAL ID：200901050496560286   Update date: Aug. 16, 2024

Hiwasa Takaki

ヒワサ タカキ | Hiwasa Takaki
Affiliation and department：
Chiba University Graduate School of Medicine, Department of Neurological Surgery

About Chiba University Graduate School of Medicine, Department of Neurological Surgery


Job title： Professor
Homepage URL  (1)： https://www.m.chiba-u.jp/dept/neurosurgery/
Research field  (1)： Medical biochemistry
Research keywords  (7)： proteases and their inhibitors ,  自己免疫疾患における自己抗体 ,  Autoantibody biomarker ,  Atherosclerosis-related disease ,  Cancer biomarker ,  SEREX ,  Gene functional analysis, DSPA
Research theme for competitive and other funds  (23)：
  • 2019 - 2024 自己抗体マーカーによる睡眠時無呼吸症候群の脳梗塞・心筋梗塞発症予測とモニタリング
  • 2016 - 2022 The Montoring Study on Esophageal Cancer by Serum Autoantibody Targeting RalA and/or NY-ESO-1
  • 2018 - 2021 Comprehensive search of autoantibies in neuroimmunological disorders using a novel hybrid SEREX-FACS method
  • 2017 - 2020 Epidemiological study on the elaboration of the prediction of cerebral infarction by autoantibody markers
  • 2016 - 2019 A potential biomaker with circulating auto-antibodies for cardiovascular disease in patients with obstructive sleep apnea
Show all
Papers (119)：
  • Takaki Hiwasa, Yoichi Yoshida, Masaaki Kubota, Shu-Yang Li, Bo-Shi Zhang, Tomoo Matsutani, Seiichiro Mine, Toshio Machida, Masaaki Ito, Satoshi Yajima, et al. Serum anti-KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases. Medicine International. 2024. 4. 5. 45
  • Bo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, Satoshi Yajima, Kimihiko Yoshida, Mikiko Ohno, Eiichiro Nishi, Hao Wang, Shu-Yang Li, Masaaki Kubota, et al. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases. International journal of molecular sciences. 2024. 25. 9
  • Sohei Kobayashi, Takaki Hiwasa, Kouichi Kitamura, Masayuki Kano, Tyuji Hoshino, Sho Hirano, Mayuko Hashimoto, Masanori Seimiya, Hideaki Shimada, Fumio Nomura, et al. Combinational antibody detection approach increases the clinical validity of colorectal cancer screening. Journal of clinical laboratory analysis. 2023. e24978
  • Toshiki Namiki, Minoru Takemoto, Aiko Hayashi, Hiroki Yamagata, Takahiro Ishikawa, Koutaro Yokote, Shu-Yang Li, Masaaki Kubota, Bo-Shi Zhang, Yoichi Yoshida, et al. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus. BMC endocrine disorders. 2023. 23. 1. 239-239
  • 島田 英昭, 谷島 聡, 鈴木 隆, 大嶋 陽幸, 名波 竜規, 伊藤 正朗, 白鳥 史明, 船橋 公彦, 日和佐 隆樹. 食道癌における血清自己抗体のバイオマーカーとしての臨床病理学的意義. 日本消化器外科学会総会. 2023. 78回. P240-5
ｍore...
MISC (193)：
  • 谷島聡, 伊藤正朗, 名波竜規, 大嶋陽幸, 鈴木隆, 白鳥史明, 山川輝記, 大久保和範, 大塚由一郎, 船橋公彦, et al. 胃癌患者の解糖系酵素における血清自己抗体の解析. 日本外科学会定期学術集会(Web). 2023. 123rd
  • 山縣 弘規, 日和佐 隆樹, 大西 俊一郎, 吉田 知彦, 竹本 稔. 2型糖尿病患者における血中抗GIP抗体、抗GLP-1抗体測定の臨床的意義に関する検討. 糖尿病. 2022. 65. Suppl.1. S-225
  • 谷島聡, 伊藤正朗, 白鳥史明, 鈴木隆, 名波竜規, 大嶋陽幸, 大久保和範, 大塚由一郎, 船橋公彦, 日和佐隆樹, et al. 胃癌手術症例における血清抗Enolase1抗体の解析. 日本外科学会定期学術集会(Web). 2022. 122nd
  • 谷島聡, 伊藤正朗, 名波竜規, 白鳥史明, 鈴木隆, 大嶋陽幸, 大塚由一郎, 船橋公彦, 日和佐隆樹, 島田英昭. 腫瘍抗原を標的とする胃癌新規抗体マーカーのスクリーニング. 日本外科学会定期学術集会(Web). 2021. 121st
  • 白鳥史明, 日和佐隆樹, 伊藤正朗, 伊藤正朗, 鈴木隆, 谷島聡, 名波竜規, 大嶋陽幸, 船橋公彦, 島田英昭, et al. 食道癌患者血清におけるDAN抗体レベルの上昇. 日本食道学会学術集会抄録集(CD-ROM). 2021. 75th
ｍore...
Patents (11)：
ｍore...
Education (2)：
  • 1975 - 1980 The University of Tokyo Graduate School of Science Department of Biophysics and Biochemistry
  • 1971 - 1975 The University of Tokyo Faculty of Science Department of Biophysics and Biochemistry
Professional career (1)：
  • Ph.D. (The University of Tokyo)
Work history (4)：
  • 2023/04 - 現在 Chiba University Graduate School of Medicine, Department of Neurological Surgery
  • 2022/10 - 2025/09 Jinan University
  • 2018/04 - 2023/03 Chiba University Graduate School of Medicine Professor
  • 1997/04 - 2018/03 Chiba University Graduate School of Medicine
Association Membership(s) (1)：
日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM